CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The SAVETHEHEART project focuses on developing a novel treatment for cardiac fibrosis using liposomes to deliver Dapagliflozin, a diabetes medication. By utilizing advanced bioprinting techniques to create a realistic 3D model of cardiac tissue, the project aims to enhance understanding of cell behavior and optimize dr…
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, with half of CVDs deaths being caused by coronary artery disease.
Myocardial infarction is the most common cause of cardiac insufficiency, leading to fibrosis and ultimately heart failure.
Since current therapies for cardiac fibrosis have limitations, there is a need for more effective strategies.
Gliflozins (e.g., Dapagliflozin and Empagliflozin), hypoglycemic agents and SGLT2 inhibitors usually used for the treatment of t…
UNIVERSITAIR MEDISCH CENTRUM GRONINGEN
ACADEMISCH ZIEKENHUIS GRONINGEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
